These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1295817)

  • 21. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism.
    Fryburg DA
    Am J Physiol; 1994 Aug; 267(2 Pt 1):E331-6. PubMed ID: 8074213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of rhGH and rhIGF-1 on renal growth and morphology.
    Mehls O; Irzynjec T; Ritz E; Eden S; Kovàcs G; Klaus G; Floege J; Mall G
    Kidney Int; 1993 Dec; 44(6):1251-8. PubMed ID: 7905540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of recombinant human insulin-like growth factor-1 and recombinant human growth hormone on anabolism and immunity in calorie-restricted alcoholic rats.
    Mendenhall CL; Roselle GA; Gartside P; Grossman CJ
    Alcohol Clin Exp Res; 1997 Feb; 21(1):1-10. PubMed ID: 9046366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of rhGH and rhIGF-I treatment on protein utilization in elderly women.
    Butterfield GE; Thompson J; Rennie MJ; Marcus R; Hintz RL; Hoffman AR
    Am J Physiol; 1997 Jan; 272(1 Pt 1):E94-9. PubMed ID: 9038857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
    Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
    JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
    Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
    Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
    Kupfer SR; Underwood LE; Baxter RC; Clemmons DR
    J Clin Invest; 1993 Feb; 91(2):391-6. PubMed ID: 7679407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys.
    LeRoith D; Yanowski J; Kaldjian EP; Jaffe ES; LeRoith T; Purdue K; Cooper BD; Pyle R; Adler W
    Endocrinology; 1996 Mar; 137(3):1071-9. PubMed ID: 8603576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined treatment with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female rats.
    Sundström K; Cedervall T; Ohlsson C; Camacho-Hübner C; Sävendahl L
    Endocrinology; 2014 Dec; 155(12):4798-807. PubMed ID: 25243853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone.
    Gosteli-Peter MA; Winterhalter KH; Schmid C; Froesch ER; Zapf J
    Endocrinology; 1994 Dec; 135(6):2558-67. PubMed ID: 7527334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients.
    Garibotto G; Barreca A; Russo R; Sofia A; Araghi P; Cesarone A; Malaspina M; Fiorini F; Minuto F; Tizianello A
    J Clin Invest; 1997 Jan; 99(1):97-105. PubMed ID: 9011582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.
    Hartman ML; Clayton PE; Johnson ML; Celniker A; Perlman AJ; Alberti KG; Thorner MO
    J Clin Invest; 1993 Jun; 91(6):2453-62. PubMed ID: 8514857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans.
    Horber FF; Marsh HM; Haymond MW
    Diabetes; 1991 Jan; 40(1):141-9. PubMed ID: 2015969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human growth hormone prevents the protein catabolic side effects of prednisone in humans.
    Horber FF; Haymond MW
    J Clin Invest; 1990 Jul; 86(1):265-72. PubMed ID: 2195062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes.
    Wurzburger MI; Prelevic GM; Sönksen PH; Balint-Peric LA; Wheeler M
    J Clin Endocrinol Metab; 1993 Jul; 77(1):267-72. PubMed ID: 8325951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
    Lucidi P; Lauteri M; Laureti S; Celleno R; Santoni S; Volpi E; Angeletti G; Santeusanio F; De Feo P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery.
    Mauras N; Martha PM; Quarmby V; Haymond MW
    Am J Physiol; 1997 Apr; 272(4 Pt 1):E628-33. PubMed ID: 9142884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans.
    Oehri M; Ninnis R; Girard J; Frey FJ; Keller U
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E552-8. PubMed ID: 8928758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.